Anika Therapeutics, Inc. (ANIK) SEC Filings — 2024

Filings

• Anika Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Anika Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 4, 2024
• Anika Therapeutics Files 8-K on Financials — 8-K · Oct 31, 2024
• Anika Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Oct 23, 2024
• Anika Therapeutics Q2 2024 10-Q Filed — 10-Q · Aug 8, 2024
• Anika Therapeutics Reports on Shareholder Votes — 8-K · Jul 11, 2024
• Anika Therapeutics Files Proxy Materials — DEFA14A · Jun 25, 2024
• Anika Therapeutics Files DEF 14A for 2023 Executive Compensation — DEF 14A · Jun 11, 2024
• Caligan Partners Amends Anika Therapeutics Stake — SC 13D/A · May 30, 2024
• Anika Therapeutics Appoints New Chief Medical Officer — 8-K · May 28, 2024
• Anika Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
• Anika Therapeutics Files 10-K/A Amendment — 10-K/A · Apr 26, 2024
• Anika Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Apr 5, 2024
• Anika Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 15, 2024
• Anika Therapeutics Files 8-K on Financials — 8-K · Mar 13, 2024
• Caligan Partners Amends Anika Therapeutics Stake — SC 13D/A · Mar 6, 2024
• Anika Therapeutics Reports Officer Compensation Changes, Board Updates — 8-K · Feb 26, 2024
• Vanguard Trims Anika Therapeutics Stake to 8.7% — SC 13G/A · Feb 13, 2024
• Trigran Investments Amends Anika Therapeutics Stake — SC 13G/A · Feb 9, 2024
• Dimensional Fund Advisors Holds 8.0% Stake in Anika Therapeutics — SC 13G/A · Feb 9, 2024
• BlackRock Amends Anika Therapeutics Stake as of Dec 31, 2023 — SC 13G/A · Jan 24, 2024
• State Street Corp Updates Anika Therapeutics Stake in SC 13G/A — SC 13G/A · Jan 22, 2024